Following identification of a potential project in the ESOS report, EECO2 Ltd was appointed to carry out a detailed feasibility study, for the recirculation of air from the exhaust system back to the supply air handling unit (AHU) at this Active Pharmaceutical Ingredient – API R&D facility.
The report concluded that with a structured, risk-based approach, energy savings of £80,000 per year can be delivered, with a payback less than 2 years. API facilities have great potential for improving safety monitoring while achieving more efficient HVAC operation following a systematic risk-based approach to project development.
To read more about how the EECO2 team developed the project savings, take a look at the case study.
Does you API R&D site require an energy efficiency assessment or feasibility study? Get in touch with EECO2 and see what we can do for you!
Follow EECO2 on Twitter or LinkedIn for more News Updates like this one – “Recirculation Feasibility Study at API R&D Facility”.